Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results

References

• Santos-Moreno P, Castañeda O, Garro B, Flores D, Sánchez G, Castro C. From the model of integral attention to the creation of centers of excellence in rheumatoid arthritis. Clin Rheumatol. 2015;34(S1):71–77. doi:10.1007/s10067-015-3017-825344775
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Galarza-Maldonado C, Caballero-Uribe CV, et al. REAL-PANLAR project for the implementation and accreditation of centers of excellence in rheumatoid arthritis throughout Latin America: a consensus position paper from REAL-PANLAR group on improvement of rheumatoid arthritis care in Latin America establishing centers of excellence. J Clin Rheumatol. 2015;21(4):175–180. doi:10.1097/RHU.000000000000024726010179
   PubMed Web of Science ®Google Scholar
• Santos-Moreno P, Caballero-Uribe CV, Cardiel MH, et al. A consensus position paper from REAL-PANLAR group about the methodological approach for the accreditation process of centers of excellence in rheumatoid arthritis in Latin America. J Clin Rheumatol. 2019;25(1):54–58.29596208
   PubMed Web of Science ®Google Scholar
• Santos-Moreno PI, de la Hoz-valle J, Villarreal L, Palomino A, Sánchez G, Castro C. Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study. Clin Rheumatol. 2015;34(2):215–220. doi:10.1007/s10067-014-2794-925318612
   PubMed Web of Science ®Google Scholar
• Stoffer MA, Smolen JS, Woolf A, et al. Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project. Ann Rheum Dis. 2014;73(5):902–905. doi:10.1136/annrheumdis-2013-20374323921994
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud y Protección S. Política de atención integral en salud. Minsalud; 2016:1–94.
   Google Scholar
• Pan American Health Organization. Access to High-Cost Medicines in the Americas: Situation, Challenges and Perspectives. 2010:81.
   Google Scholar
• Hu H, Luan L, Yang K, Li S-C. Burden of rheumatoid arthritis from a societal perspective: a prevalence-based study on cost of illness for patients with rheumatoid arthritis in China. Int J Rheum Dis. 2018;21(8):1572–1580.28211251
   PubMed Web of Science ®Google Scholar
• Barrera Castro SM, Suárez Moya ÁMG, Mora LM, Cardona C, Jáuregui Cuartas EA, Muñoz Urrego YA. Aproximación de discapacidad en artritis reumatoide. Resultados de un programa de atención integral. Rev Colomb Reumatol. 2017;24(3):138–144.
   Google Scholar
• Santos-Moreno P, Caballero-Uribe CV, Massardo ML, et al. Systematic and progressive implementation of the centers of excellence for rheumatoid arthritis: a methodological proposal. Clin Rheumatol. 2017;36(12):2855–2858.28840387
   PubMed Web of Science ®Google Scholar
• Valencia O, Lopes G, Sánchez P, Acuña L, Uribe D, González J. Incidence and prevalence of cancer in Colombia: the methodology used matters. J Glob Oncol. 2017;4:1–7. Available from: http://ascopubs.org/doi/10.1200/JGO.17.00008. Accessed October 20, 2020.
   Web of Science ®Google Scholar
• Ministerio de Salud y Protección Social. Resolución 5926 De 2014. 2014:1–48.
   Google Scholar
• Bossert T. Inter-American Development Bank, (IDB Technical Note ; 585).Comparative Review of Health System Integration in Selected Countries in Latin America. Available from: https://publications.iadb.org/en/publication/11898/comparative-review-health-system-integration-selected-countries-latin-america. 1, 2014.
   Google Scholar
• MSPS. Resolucion 1393 De 2015 [Internet]. Colombia; 2015:14 Available from: https://cuentadealtocosto.org/site/images/Resolucion 1393 de 2015 - ARTRITIS.pdf. Accessed 1020, 2020.
   Google Scholar
• Yazdany J, Myslinski R, Johansson T, Kazi S. OP0068 practices participating in the ACR’S rheumatology informatics system for effectiveness (RISE) national registry show improvements in quality of care. Ann Rheum Dis. 2017;79:2–80. Available from: http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2017-eular.5640. Accessed October 20, 2020.
   Web of Science ®Google Scholar
• Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509. doi:10.1136/annrheumdis-2013-20457324161836
   PubMed Web of Science ®Google Scholar
• Prevoo MLL, Van’T Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty‐eight‐joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–48. doi:10.1002/art.17803801077818570
   PubMed Web of Science ®Google Scholar
• Bruce B, Fries JF. The stanford health assessment questionnaire: dimensions and practical applications [internet]. Health Qual Life Outcomes. 2003;1:20. doi:10.1186/1477-7525-1-2012831398
   PubMedGoogle Scholar
• Pilar C, Camargo B, Eliana L, Ruiz G. Análisis de la Variación de los Costos de los Medicamentos de Artritis Reumatoide en Una eps en la Ciudad de Bogotá, 2009 – 2011 [Internet]. Pontificia Universidad Javeriana; 2012 Available from: https://repository.javeriana.edu.co/bitstream/handle/10554/1847/BecerraCamargoClaudiaPilar2012.pdf?sequence=1. Accessed 1020, 2020.
   Google Scholar
• Lurie JD, Bell JE, Weinstein J. What rate of utilization is appropriate in musculoskeletal care? Clin Orthop Relat Res. 2009;467(10):2506–11. doi:10.1007/s11999-009-0889-4.
   Google Scholar
• Badamgarav E, Croft JD, Hohlbauch A. Effects of disease management programs on functional status of patients with rheumatoid arthritis. Arthritis Rheum. 2003;49(3):377–387. doi:10.1002/art.1112012794794
   PubMed Web of Science ®Google Scholar
• Gleason PP, Alexander GC, Starner CI, et al. Health plan utilization and costs of specialty drugs within 4 chronic conditions. J Manag Care Pharm. 2013;19(7):542–548.23964615
   PubMed Web of Science ®Google Scholar
• Kawatkar AA, Jacobsen SJ, Levy GD, Medhekar SS, Venkatasubramaniam KV, Herrinton LJ. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Arthritis Care Res. 2012;64(11):1649–1656.
   PubMed Web of Science ®Google Scholar
• Brooks PM. The burden of musculoskeletal disease–a global perspective. Clin Rheumatol. 2006;25(6):778–781.16609823
   PubMed Web of Science ®Google Scholar
• Michet CJ, Strobova K, Achenbach S, Crowson CS, Matteson EL. Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota. Mayo Clin Proc. 2015;90(2):176–183.25659235
   PubMed Web of Science ®Google Scholar
• Briggs AM, Fary RE, Slater H, et al. Disease-specific knowledge and clinical skills required by community-based physiotherapists to co-manage patients with rheumatoid arthritis. Arthritis Care Res. 2012;64(10):1514–1526. doi:10.1002/acr.21727
   Web of Science ®Google Scholar
• Voshaar MJH, Nota I, Van De Laar MAFJ, Van Den Bemt BJF. Patient-centred care in established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2015;29(4–5):643–663. doi:10.1016/j.berh.2015.09.00726697772
   PubMed Web of Science ®Google Scholar
• Laires PA, Exposto F, Mesquita R, Martins AP, Cunha-Miranda L, Fonseca JE. Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries. Eur J Heal Econ. 2013;14(6):875–885. doi:10.1007/s10198-012-0432-5
   Web of Science ®Google Scholar
• Ruiz R, Strasser-Weippl K, Touya D, et al. Improving access to high-cost cancer drugs in Latin America: much to be done. Cancer. 2017;123(8):1313–1323.28182258
   PubMed Web of Science ®Google Scholar
• Michaud K, Berglind N, Franzén S, et al. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease. Ann Rheum Dis. 2016;75(10):1797–1805.26857699
   PubMed Web of Science ®Google Scholar
• Navarro-Compán V, Smolen JS, Huizinga TWJ, et al. Quality indicators in rheumatoid arthritis: results from the METEOR database. Rheumatol. 2015;54(9):1630–1639.
   Web of Science ®Google Scholar
• Mahmood S, Lesuis N, Van Tuyl LHD, Van Riel P, Landewé R. Quality in rheumatoid arthritis care. Best Pract Res Clin Rheumatol. 2015;29(4–5):664–679. doi:10.1016/j.berh.2015.09.00926697773
   PubMed Web of Science ®Google Scholar
• El Miedany Y. Adopting patient-centered care in standard practice: pROMs moving toward disease-specific era. Clin Exp Rheumatol. 2014;32(14):S40–S46.25268661
   PubMed Web of Science ®Google Scholar
• Wang BCM, Hsu P-N, Furnback W, et al. Estimating the economic burden of rheumatoid arthritis in Taiwan using the National Health Insurance Database. Drugs Real World Outcomes. 2016;3(1):107–114. doi:10.1007/s40801-016-0063-827747810
   PubMedGoogle Scholar
• Ministerio de Salud. Resolución 8430 De 1993. Vol. 1993 Minist Salud y Protección Soc República Colomb; Octubre 4, 1993:1–19.
   Google Scholar